Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53-PUMA Apoptosis Pathway.
Saved in:
| Title: | Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53-PUMA Apoptosis Pathway. |
|---|---|
| Authors: | Tsai HC; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; School of Traditional Chinese Medicine, Chang Gung University, Taoyuan, Taiwan., Wei KC; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Department of Neurosurgery, New Taipei Municipal TuCheng Hospital, Chang Gung Memorial Hospital, New Taipei City, Taiwan.; Neuroscience Research Center, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; School of Medicine, Chang Gung University, Taoyuan, Taiwan., Chen PY; School of Medicine, Chang Gung University, Taoyuan, Taiwan.; Department of Neurosurgery, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan., Huang CY; Department of Neurosurgery, New Taipei Municipal TuCheng Hospital, Chang Gung Memorial Hospital, New Taipei City, Taiwan.; Neuroscience Research Center, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan., Chen KT; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Neuroscience Research Center, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan., Lin YJ; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; School of Medicine, Chang Gung University, Taoyuan, Taiwan., Cheng HW; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Institute of Pharmacology, College of Medicine, National Yang-Ming University, Taipei, Taiwan., Chen YR; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan., Wang HT; Institute of Pharmacology, College of Medicine, National Yang-Ming University, Taipei, Taiwan.; Institute of Pharmacology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Institute of Food Safety and Health Risk Assessment, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Doctor Degree Program in Toxicology, Kaohsiung Medical University, Kaohsiung, Taiwan. |
| Source: | Frontiers in oncology [Front Oncol] 2021 Oct 01; Vol. 11, pp. 722754. Date of Electronic Publication: 2021 Oct 01 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34660288 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53-PUMA Apoptosis Pathway. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tsai+HC%22">Tsai HC</searchLink>; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; School of Traditional Chinese Medicine, Chang Gung University, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Wei+KC%22">Wei KC</searchLink>; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Department of Neurosurgery, New Taipei Municipal TuCheng Hospital, Chang Gung Memorial Hospital, New Taipei City, Taiwan.; Neuroscience Research Center, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; School of Medicine, Chang Gung University, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+PY%22">Chen PY</searchLink>; School of Medicine, Chang Gung University, Taoyuan, Taiwan.; Department of Neurosurgery, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Huang+CY%22">Huang CY</searchLink>; Department of Neurosurgery, New Taipei Municipal TuCheng Hospital, Chang Gung Memorial Hospital, New Taipei City, Taiwan.; Neuroscience Research Center, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+KT%22">Chen KT</searchLink>; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Neuroscience Research Center, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+YJ%22">Lin YJ</searchLink>; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; School of Medicine, Chang Gung University, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Cheng+HW%22">Cheng HW</searchLink>; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Institute of Pharmacology, College of Medicine, National Yang-Ming University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+YR%22">Chen YR</searchLink>; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Wang+HT%22">Wang HT</searchLink>; Institute of Pharmacology, College of Medicine, National Yang-Ming University, Taipei, Taiwan.; Institute of Pharmacology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Institute of Food Safety and Health Risk Assessment, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Doctor Degree Program in Toxicology, Kaohsiung Medical University, Kaohsiung, Taiwan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2021 Oct 01; Vol. 11, pp. 722754. <i>Date of Electronic Publication: </i>2021 Oct 01 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34660288 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2021.722754 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 722754 Titles: – TitleFull: Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53-PUMA Apoptosis Pathway. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tsai HC – PersonEntity: Name: NameFull: Wei KC – PersonEntity: Name: NameFull: Chen PY – PersonEntity: Name: NameFull: Huang CY – PersonEntity: Name: NameFull: Chen KT – PersonEntity: Name: NameFull: Lin YJ – PersonEntity: Name: NameFull: Cheng HW – PersonEntity: Name: NameFull: Chen YR – PersonEntity: Name: NameFull: Wang HT IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2021 Oct 01 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 11 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |